Table 4. Multivariable analysis of discordant versus concordant empiric antimicrobial drug therapy in patients with multidrug-resistant Acinetobacter infections, Baltimore hospitals, 2003–2004*.
Outcome evaluated | Discordant vs. concordant empiric antimicrobial drug therapy† |
|
---|---|---|
OR (95% CI) | p value | |
Length of stay, d | 1.6 (0.4–6.5) | 0.54 |
Intensive care unit length of stay, d | 5.8 (1.2–27.1) | 0.03 |
Mortality rate (%) | 0.7 (0.1–4.5) | 0.74 |
*OR, odds ratio; CI, confidence interval. †Model includes modified Acute Physiology and Chronic Health Evaluation III score to control for severity of illness and Charlson index to control for underlying disease.